vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Patient Education

  • Educate patient, friends & relatives about the disease
    • It is important for them to overcome any stigmas they may have about vitiligo
  • Explain the nature of the disease to the patient
    • Vitiligo does not effect the patient’s health directly, but is a cosmetic issue
    • Spontaneous recovery may occur
  • Treatment options should be discussed
    • Treatment may be long & difficult, & the results are often unpredictable
    • Review the risks vs benefits along w/ expected outcomes of the treatment options
Editor's Recommendations
Most Read Articles
08 Oct 2017
Treatment with vismodegib does not appear to increase the risk of subsequent squamous cell carcinoma (SCC) in comparison with standard surgical treatment of basal cell carcinoma (BCC), a recent study suggests.
Tristan Manalac, 25 Aug 2017
Using blunt needles to administer local anaesthesia in upper blepharoplasty has a lower risk of haemorrhage and need for interventional pain procedures compared with sharp needles, a new randomized clinical trial has found.
24 Sep 2017
The variation in the atopic march (asthma and seasonal allergies) may be partly explained by the timing of atopic dermatitis onset, suggests a recent study.
11 Sep 2017
Severe psoriasis significantly increases the risk of atrial fibrillation (AF) and thromboembolic events (AE), a recent nationwide population-based study from Korea has shown.